Navigation Links
New CoMotion(R) Trials Software by General Dynamics Enables Rapid, Interactive Sharing of Real-time Data for Clinical Trials
Date:4/28/2008

Software enables clinical-trial researchers, analysts and managers to visualize and collaborate across the room or around the world, in real-time

SCOTTSDALE, Ariz., April 28 /PRNewswire/ -- General Dynamics Viz, a part of General Dynamics C4 Systems, introduces CoMotion(R) Trials, a collaborative, decision-support software tool that enables hundreds of researchers, analysts and managers to see, analyze, share and comment on data and information produced throughout the clinical trials process. The software, which runs on a commercial off-the-shelf computer, integrates data from many separate systems, portraying it in easily configurable charts and visualizations.

Required by the U.S. government, clinical trials comprise rigorous research, testing and analysis of the safety and effectiveness of new pharmaceuticals and medical equipment. A clinical trial can last several years and involve measurement and analysis of information from thousands of patients in hospitals, clinics or other medical facilities located worldwide. As more trials adopt computer-based systems to capture electronic data, the volume and complexity of information increases. As a result, software-based tools are needed to streamline the organization, interpretation and decision-making responsibilities that clinical trials teams must complete.

"With this software, clinical trials stakeholders don't have to stitch emails, wikis and sticky-notes together for the big-picture view of what's happening during a clinical trial," said Mike Capsambelis, product management director for General Dynamics Viz. "CoMotion Trials streamlines the flow of information during every phase of the clinical trials process, and that means significant cost and time savings for everyone involved."

CoMotion Trials is built on General Dynamics' CoMotion(R) software technology, currently used in the life sciences industry and by the U.S. government and military. For the military, CoMotion is part of an established battle management system that enables commanders and their staffs to collaboratively develop operational plans, then monitor plan rehearsal and execution from geographically dispersed headquarters.

General Dynamics C4 Systems, a business unit of General Dynamics (NYSE: GD), is a leading integrator of secure communication and information systems and technology.

General Dynamics, headquartered in Falls Church, Va., employs approximately 83,500 people worldwide and reported 2007 revenues of $27.2 billion. The company is a market leader in business aviation; land and expeditionary combat systems, armaments and munitions; shipbuilding and marine systems; and information systems and technologies. More information about the company is available on the Internet at http://www.generaldynamics.com.


'/>"/>
SOURCE General Dynamics C4 Systems
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
3. PNH Patients Treated with Soliris(TM) Experienced Dramatic Reduction in Blood Clots During Clinical Trials
4. Multiple NIH Phase 2 HIV Vaccine Trials Using Vicals Technology Produce Encouraging Results
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
7. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
8. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
11. BiPar Expands Management Team to Advance Lead PARP Inhibitor Product Candidate Into Phase 2 Trials for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2017)... and INDIANAPOLIS , June 9, ... living with diabetes. In a further effort to help ... affected by this condition, the International Diabetes Federation (IDF) ... ) have come together for the second phase of ... Systems programme (BRIDGES 2), reaffirming their commitment to helping ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/2/2017)... LAWRENCE, Mass. , June 2, 2017  NxStage ... advancing renal care, today announced new findings demonstrating positive ... NxStage ® System One™. The data will be ... 2017, in Madrid, Spain . ... Knowledge to Improve Home Dialysis Network in ...
Breaking Medicine Technology:
(Date:6/25/2017)... ... June 25, 2017 , ... June is Men’s Health Month and the ... common cancer among men in the U.S. and the third most common cause of cancer ... that one man in seven will be diagnosed with prostate cancer during his lifetime. ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating ... outdoors. Home and business owners should be aware that the summer months provide more ... fact, mechanical locks and keys can be negatively affected from direct exposure to the ...
(Date:6/23/2017)... ... 23, 2017 , ... By scoring 100% for fiscal management and accountability, the ... online charity evaluator, Charity Navigator, validating ANRF's work as a top charity in America. ... Charity Navigator and earns ANRF a spot on their “ 10 Charities Worth Watching ...
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran Y. ... has recently begun offering three new minimally invasive procedures to patients who want ... reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and platelet ...
(Date:6/23/2017)... ... ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique approach to ... technique that he calls the AuraLyft Facelift. The AuraLyft does more than ... expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique approach stems ...
Breaking Medicine News(10 mins):